Related Experiment Video
Updated: Dec 24, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice
David Reiss1,2,3,4, Tando Maduna1,2,3,4,5, Hervé Maurin1,2,3,4
1Translational Medicine and Neurogenetics Department, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
Abstract:
A major challenge in medicine is developing potent pain therapies without the adverse effects of opiates. Neuroinflammation and in particular microglial activation have been shown to contribute to these effects. However, the implication of the microglial mu opioid receptor (MOR) is not known. We developed a novel conditional knockout (cKO) mouse line, wherein MOR is deleted in microglia. Morphine analgesic tolerance was delayed in both sexes in cKO mice in the hot plate assay. Opioid-induced hyperalgesia (OIH) as measured in the tail immersion assay was abolished in male cKO mice, and physical dependence to morphine as assessed by naloxone-induced withdrawal was attenuated in female cKO mice. Our results show a sex-dependent contribution of microglial MOR in morphine analgesic tolerance, OIH, and physical dependence. In conclusion, our data suggest that blockade of microglial MOR could represent a therapeutic target for opiate analgesia without the opiate adverse effects.
Insights
Targeting microglial mu opioid receptors (MOR) may offer new pain relief. Deleting MOR in microglia delayed tolerance and reduced side effects like hyperalgesia and dependence, suggesting a novel therapeutic approach.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- Opioid analgesics are effective but cause adverse effects.
- Neuroinflammation, particularly microglial activation, contributes to opioid side effects.
- The role of the microglial mu opioid receptor (MOR) in these effects is unclear.
Purpose of the Study:
- To investigate the role of microglial MOR in opioid analgesia, tolerance, hyperalgesia, and dependence.
- To develop and utilize a novel conditional knockout (cKO) mouse model to delete MOR specifically in microglia.
Main Methods:
- Generated a conditional knockout (cKO) mouse line with MOR deleted in microglia.
- Assessed morphine analgesic tolerance using the hot plate assay.
- Measured opioid-induced hyperalgesia (OIH) via tail immersion assay.
- Evaluated physical dependence using naloxone-induced withdrawal.
Main Results:
- Morphine analgesic tolerance was delayed in both sexes of cKO mice.
- OIH was abolished in male cKO mice.
- Morphine physical dependence was attenuated in female cKO mice.
- Demonstrated a sex-dependent role for microglial MOR.
Conclusions:
- Microglial MOR plays a significant, sex-dependent role in morphine's effects.
- Blocking microglial MOR may be a therapeutic strategy for opioid analgesia.
- This approach could mitigate adverse effects associated with opioid use.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
06:54Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners